Kinfo
AstraZeneca PLC American Depositary Shares logo

AstraZeneca PLC American Depositary Shares

AZNNASDAQHealthcare·US · USD
$186.76
-2.63 (-1.39%)
Prices as of November 10, 2026 · market closed

Price

Key statistics

Valuation
Market cap293.73B USD
Enterprise value315.40B USD
Trailing P/E26.67
Forward P/E16.66
PEG ratio14.04
Price / sales4.69
Price / book5.65
Profitability
Gross margin83.60%
Operating margin29.57%
Profit margin17.68%
Return on assets8.58%
Return on equity22.57%
Income (TTM)
Revenue62.38B USD
Gross profit51.02B USD
EBITDA20.44B USD
Net income11.03B USD
Diluted EPS$7.07
Rev. growth (YoY)6.70%
Balance sheet
Total cash8.17B USD
Total debt34.33B USD
Debt / equity66.25
Current ratio1.01
Book value / share$33.35
Cash flow (TTM)
Operating cash flow13.23B USD
Levered free cash flow5.63B USD
Shares & price
Shares outstanding1.55B
Float1.54B
Held by institutions76.63%
Beta0.16
50-day MA$166.47
200-day MA$180.22
52-week high$212.71
52-week low$153.41
Dividends
Forward rate
$4.31
Yield
2.27%
Payout ratio
45.38%
Frequency
Semi-Annual
Recent payments
  • 2026-02-19$2.15
Earnings (EPS)
DateEst.ActualSurprise2026-10-301.151.00−13.04%2026-07-271.251.32+5.60%2026-04-291.271.29+1.57%2026-01-300.420.36−14.29%2025-11-061.131.19+5.31%
About AstraZeneca PLC American Depositary Shares

AstraZeneca PLC American Depositary Shares represent ownership in AstraZeneca PLC, a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. AstraZeneca’s current business spans Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. The company develops and markets treatments used across hospitals, clinics, and specialty care settings, serving patients and healthcare providers in major therapeutic areas with high unmet medical need. Its portfolio is built around branded medicines and regulated drug launches, with ongoing commercial activity across the United States, Europe, and other international markets. AstraZeneca PLC American Depositary Shares provide U.S. investors a way to hold an instrument linked to the company’s underlying shares while participating in the performance of one of the world’s largest research-driven drugmakers.

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.
Employees
96,100
Headquarters
Cambridge, United Kingdom

Frequently asked questions about AstraZeneca PLC American Depositary Shares